The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study

INTRODUCTION: The dihydroorotate dehydrogenase (DHODH) inhibitors leflunomide and teriflunomide are immunomodulatory agents approved to treat rheumatoid arthritis (RA) and multiple sclerosis, respectively, and are actively being investigated as therapeutic agents for other immune-related diseases; h...

Descripción completa

Detalles Bibliográficos
Autores principales: Muehler, Andreas, Kohlhof, Hella, Groeppel, Manfred, Vitt, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890621/
https://www.ncbi.nlm.nih.gov/pubmed/31621054
http://dx.doi.org/10.1007/s40268-019-00286-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890621/
https://www.ncbi.nlm.nih.gov/pubmed/31621054
http://dx.doi.org/10.1007/s40268-019-00286-z

Ejemplares similares